Postpartumcare.ca (Web-Enabled Intervention) for Postnatal Depression

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Women's Heath Research Institute, Vancouver, Canada
Postnatal Depression+10 More
Postpartumcare.ca (Web-Enabled Intervention) - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test how well postpartumcare.ca works to help postpartum depression and anxiety in British Columbia. An online intervention called postpartumcare.ca is being used to treat postnatal depression in this study. This treatment has been previously approved by the FDA for a different condition. All patients in this trial will be receiving the active treatment, and there will be no placebo group.

Eligible Conditions

  • Postnatal Depression
  • Postpartum Disorder
  • Perinatal Disorder
  • Postpartum Depression
  • Perinatal Depression
  • Anxiety

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Study Objectives

7 Primary · 0 Secondary · Reporting Duration: The PASS will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period

The EPDS will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period
Change from Baseline Postpartum Depression at 4 weeks and 6 weeks, evaluated using the Edinburgh Postnatal Depression Scale (EPDS).
The PASS will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period
Change from Baseline Postpartum Anxiety at 4 weeks and 6 weeks, evaluated using the Perinatal Anxiety Screening Scale (PASS).
Website metrics will be collected after the 4-week intervention period for the intervention group only
Website metrics including average time on page, average session duration, returning visitors, and number of pages visited per session.
Website satisfaction will be evaluated after the 4-week intervention period for the intervention group only
Website satisfaction, evaluated using the Patient Education Materials Assessment Tool (PEMAT)
Website satisfaction, evaluated using the Patient Global Impression of Change (PGIC) questionnaire
Website satisfaction, evaluated using the user-perceived web quality instrument
Website usability will be evaluated after the 4-week intervention period for the intervention group only
Website usability, as evaluated using the System Usability Scale (SUS)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Waitlist Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Postpartumcare.ca (Web-Enabled Intervention) · No Placebo Group · Phase 3

Intervention
Other
Experimental Group · 1 Intervention: Postpartumcare.ca (Web-Enabled Intervention) · Intervention Types: Other
Waitlist ControlNoIntervention Group · 1 Intervention: Waitlist Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: the pass will be administered at baseline, after a 4-week intervention period, and again after a 2-week follow up period
Closest Location: Women's Heath Research Institute · Vancouver, Canada
Photo of Vancouver 1Photo of Vancouver 2Photo of Vancouver 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Postnatal Depression
0 CompletedClinical Trials

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,296 Previous Clinical Trials
1,271,207 Total Patients Enrolled
Women's Health Research Institute of British ColumbiaOTHER
5 Previous Clinical Trials
16,198 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,216 Previous Clinical Trials
24,391,914 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be a resident of British Columbia.
You are at least 19 years of age.
You have access to study materials online.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.